Full-Time
Pharmacy Assistant
Posted on 5/15/2025
felix
201-500 employees
Telemedicine platform with at-home prescription delivery
Compensation Overview
CA$20/hr
Mississauga, ON, Canada
In Person
 Medical, Clinical & Veterinary (1) |
|---|
- Education: High school diploma, GED, or equivalent; must be at least 18 years old.
- Experience: Minimum 1 year of experience in pharmacy.
- Detail-Oriented: High level of accuracy in medication handling, labelling, and data entry.
- Communication Skills: Clear, professional, and fluent in English (written and verbal).
- Team Player: Able to collaborate in a fast-paced environment while staying organized and focused.
- Tech-Savvy: Comfortable working with pharmacy software and digital tools; experience with Kroll is strongly preferred.
- Safety-Focused: Committed to following health and safety protocols and maintaining a safe workspace.
- Accurately register patients, create and maintain up-to-date profiles, and input prescription history in our pharmacy system.
- Assist with the preparation, labelling, packaging, and shipment of prescription medications under the supervision of a pharmacist.
- Respond to inquiries from doctors and patients, and escalate clinical questions to the pharmacist when appropriate.
- Help manage pharmacy inventory and packaging supplies; support coordination of medication orders with wholesalers and manufacturers.
- Ensure accurate documentation and uphold pharmacy data integrity across all systems and processes.
- Follow all safety procedures and contribute to a clean, organized, and compliant work environment.
- Experience with Kroll is strongly preferred.
Felix is a Canadian digital health service that enables patients to access medical treatment online without visiting a doctor’s office or pharmacy. It operates a telemedicine platform where patients answer health questions, a network of healthcare professionals reviews the information and creates a personalized treatment plan, and prescribed medications are shipped directly to the patient’s home in discreet packaging at no extra cost. Revenue comes from consultation fees and medication sales, with the goal of providing convenient, private, and timely care. Felix differentiates itself through its emphasis on compassionate, non-judgmental support, discreet home delivery, and a large, trusting user base of over 500,000 Canadians. Overall, Felix aims to remove barriers to care by combining online access, professional medical guidance, and free home delivery to improve patient access and privacy.
Company Size
201-500
Company Stage
Late Stage VC
Total Funding
$63.7M
Headquarters
Toronto, Canada
Founded
2019
Simplify's Take
What believers are saying
- Generic GLP-1 drugs entering market in early 2026 positions Felix's scaled weight loss program for dominance.
- Menopause care driving strong growth with integrated platform differentiating from specialized competitors.
- Profitability achieved while growing enables aggressive market expansion without capital constraints.
What critics are saying
- Maple and Phoenix erode market share in stigmatized care with broader physician networks.
- Quebec regulators block expansion, excluding 25% of Canada's population permanently.
- Health Canada enforces stricter synchronous video requirements, increasing operational costs 30-50%.
What makes felix unique
- Integrated platform combines diagnosis, prescription, delivery, and ongoing care in one place.
- Operates profitably with $150M revenue run rate and 80% YoY growth as of July 2025.
- Expanded to 20+ care categories including mental health, menopause, and preventative longevity testing.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Remote Work Options
Flexible Work Hours
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 1%2 year growth
↑ 1%Why (and how) Felix Health Inc. has improved Mental Health services at Felix. Summarize this article with AI. AI-generated summaries may be inaccurate and do not constitute medical advice. Third-party AI tools are not under Felix's control, and your use of them is at your own risk. During the pandemic, mental health came to the forefront as more and more Canadians said they were facing challenges. According to polls from Mental Health Research Canada, 28% of Canadians reported high levels of anxiety and 17% reported high levels of depression while one third (32%) say either that they are, or they should be, accessing mental health support since COVID-19. Earlier this year, Felix Health Inc. announced the first version of its mental health services. Felix Health Inc. started by refilling prescriptions for mental health medications with the goal of expanding to prescribe new treatments. Today Felix Health Inc. is so proud to share that Felix Health Inc. has met that goal and are launching its expanded mental health services. People across Canada can now get new prescriptions for mental health delivered to their door. Why access to mental health treatment is crucial. Mental health affects a lot of people. If you're not directly impacted, someone you know might be. According to the Canadian Mental Health Association, 6.7 million people are living with a mental health condition in Canada and approximately 8% of adults will deal with depression at some point. Many people who are affected don't seek treatment. A recent survey conducted by the Centre for Addiction and Mental Health showed that 40% of Canadians have experienced feelings of anxiety or depression but have never sought medical help. These stats, combined with the demand from its own customers that drove Felix Health Inc. to launch mental health services in the first place, make it clear that accessible mental health treatment options are long overdue. There are too many barriers to mental health treatment. People looking to take care of themselves face significant barriers around access and stigma. To start, many Canadians, especially those in rural communities (about 20% of the population) don't have a family doctor. Plus, when it comes to talking about highly stigmatized, personal issues like anxiety and depression, not everyone is comfortable discussing them at a walk-in clinic - or even face-to-face with their own doctor. For those who do have access, almost half the people in Canada who sought mental treatment either reported their needs were only partially met or completely unmet. Felix Health Inc. need a better way, and that's why Felix Health Inc. launched the second phase of its service. How it works. Like all of its services, it starts with sharing some information during a quick online assessment. The new service may also include audio or video visits at your healthcare practitioner's discretion. After your confidential assessment, if appropriate your practitioner will prescribe the best treatment option for you, which is then filled, discreetly packaged, and shipped free within 48 hours by an accredited pharmacy. You can also ask your practitioner questions anytime (on your time) through secure messaging. By making treatment more discreet and convenient, Felix Health Inc. hope more Canadians can take care of their mental health - in ways that work for them. Its work isn't done. There is good news. Once depression is recognized, help can make a difference for 80% of people who are affected. Felix Health Inc. know that mental health treatment doesn't start and stop with medication. Its service will continue to evolve over the coming months and years through psychotherapy and more - and Felix Health Inc. can't wait to share it with you. Published on Jan 19, 2026 Published on Dec 1, 2025 Published on Nov 6, 2025 Published on Apr 30, 2025
Felix Health secures $53M in funding to accelerate profitable growth. The company announced a revenue run rate of $150M CAD, growing 80% year-over-year while achieving profitability as of July 2025. TORONTO, Oct. 23, 2025 /CNW/ - Felix Health, the leader in on-demand everyday healthcare in Canada, today announced it has closed $53M in financing led by existing investor Canadian Business Growth Fund (CBGF). The round includes participation from Business Development Bank of Canada (BDC)'s Women in Tech Venture Fund, BMO Capital Partners, Whitecap Venture Partners and H Venture Partners with support from Scotiabank. Felix provides on-demand, online treatment in 20+ categories of care from consultation and diagnosis to prescription delivery and support. The company recently launched Felix Longevity marking another milestone expansion of its circle of care, giving patients access to preventative lab testing and proactive treatment for the first time. "Felix is building a new kind of healthcare company in Canada, one that provides an accessible and holistic care experience enabled by technology, with the patient at the centre." said Kyle Zien, Felix's co-founder and CEO. "This additional funding will accelerate our mission to empower millions of Canadians to take control of their health and wellbeing." This latest round of funding marks a continuation of tremendous growth for Felix. The company announced that it has achieved a $150M revenue run rate in its current fiscal year, representing year-over-year growth of 80%. Felix achieved this while attaining profitability as of July 2025. Felix will use fundraising proceeds to expand its leadership position in the Canadian market with investments in team, the Felix brand, and category expansion including further offerings in preventative care and testing. The company will also continue to scale its market-leading weight loss offering in anticipation of generic GLP-1s coming to market in 2026. "We continue to be impressed by the tremendous growth, quality of execution and ambitious vision of Felix, as well as their deep commitment to patients," said Dale Tingley, CBGF co-managing partner. "We're thrilled to continue supporting this team and fueling their growth story." Dale Tingley will join Felix's Board of Directors. H Venture Partner's founder and managing partner Elizabeth Edwards will join the board as an observer. About Felix Health Founded in 2019, Felix provides on-demand treatment for everyday health. As a leading virtual care platform, Felix improves access to everyday healthcare, offering a seamless, stigma-free journey from diagnosis to prescription delivery and ongoing care. Over 1 million Canadians have sought out treatments from Felix aimed at menopause symptoms, birth control, weight loss, erectile dysfunction, acne, hair loss, and more. Learn more at www.felixforyou.ca.
Felix Health secures $53 million to expand telehealth services in Canada. News summary. Felix Health, a Toronto-based telehealth startup, has raised $53 million in growth financing from the Canadian Business Growth Fund (CBGF) and other investors. The funding, a mix of equity and debt, aims to support Felix's expansion in providing personalized health solutions for Canadians. Having achieved profitability in July and experiencing an 80% year-over-year growth rate, Felix is poised to scale its operations, especially in anticipation of generic weight loss drugs entering the Canadian market. The company plans to grow its team and invest in key areas such as menopause care and weight management through GLP-1 receptor agonist drugs. Felix currently operates across Canada, excluding Quebec, and has facilitated over 1 million medical consultations. The startup is also exploring new marketing strategies to enhance its visibility. Story coverage.
Felix Health raises $53 million in growth financing to get more "aggressive" in telehealth. Felix Health has secured $53 million from the Canadian Business Growth Fund (CBGF) and other existing investors as it looks to balance newfound profitability with the growth of its personalized health options for Canadians. "We saw a big opportunity for us to continue to push our lead in the market." The growth financing, which is a roughly equal mix of equity and debt, comes off a hot streak for the Toronto-based telehealth platform. It claimed it attained profitability in July while also managing 80 percent year-over-year growth, and bringing in an annual run rate of $150 million CAD (monthly revenue times 12). "We certainly weren't in a position where we needed to raise capital, but we saw a big opportunity for us to continue to push our lead in the market," Felix CEO Kyle Zien said in an exclusive interview with BetaKit. CBGF led the round, with participation from the Business Development Bank of Canada (BDC) Women in Tech Venture Fund, BMO Capital Partners, Scotiabank, Whitecap Venture Partners, and H Venture Partners. Zien declined to share Felix's valuation, but claimed the deal was a "significant up round." Investors saw an opportunity to give Felix the capital to be more "aggressive" in the market over the next couple of years, according to co-founder and COO Emma Stern. Dale Tingley, CBGF co-managing partner, told BetaKit that the company's clear growth strategy and impressive leadership made the additional investment "an easy decision." Felix was founded in 2019 to address the healthcare needs of Canadians for common issues like acne, contraception, erectile dysfunction, and hair loss. It sells therapeutics through a virtual platform that covers assessments, lab tests, prescriptions, and drug delivery, in every province except for Quebec. The company has since expanded to more than 20 categories - including mental health care, menopause, and weight loss management - which Zien said are driving strong growth. It most recently launched a "longevity" testing platform for ongoing health monitoring through biomarker tests to meet demand for preventative care. Part of this demand, the startup argues, comes from an overburdened healthcare system in Canada that faces a shortage of primary care doctors. Felix is also part of a growing list of Canadian telehealth startups, such as Phoenix and Maple, that make convenience and discretion part of their draw, particularly for stigmatized conditions. While Felix currently targets consumers directly and claims to have facilitated 1 million medical consultations, Stern said the company is continuing to explore other avenues of access. Before this round, the startup had raised more than $30 million to fuel its expansion. Felix previously told BetaKit that it saw a 100-percent increase in weight loss management patients from January to August of this year. Its program includes GLP-1 receptor agonist drugs like Ozempic that were originally developed to treat diabetes but also demonstrate efficacy for weight loss. Stern said that Felix wants to "have all our operations scaled up and ready for market" when generic GLP-1 drugs hit Canadian shelves next year. Ozempic maker Novo Nordisk's patent protection in Canada for the drug is set to expire in early 2026. Menopause care has been another driving category for Felix over the past eight to nine months, Stern said. Other Canadian tech companies, such as June Health, Coral, and Dialogue, have launched digital platforms to facilitate treatment for menopause symptoms. Stern said that Felix's menopause care stands out, however, because the platform can help patients address their other healthcare needs in the same place. While balancing profitability and growth, the company plans to use the funding to expand its team of over 150 and invest in some of its newer categories, including menopause and weight management through GLP-1s. Zien said the team is also diversifying its marketing tactics by investing in "high-profile TV moments," like commercials during Blue Jays games. "We're expanding the aperture of where you'll be able to discover the Felix platform," he said.
Felix Health, a Toronto-based startup, has raised $53 million in growth financing. The company, now newly profitable, plans to use the funds to scale its operations and become more aggressive in the telehealth sector, particularly before generic weight loss drugs become available in Canada.